Eli Lilly’s daily GLP-1 pill shows strong weight loss results without food restrictions


Eli Lilly's experimental oral pill, orforglipron, shows promise in obesity treatment, with participants experiencing an average 12% body weight loss in a Phase 3 trial. The study, involving overweight or obese adults, revealed significant weight reduction and improved cardiovascular markers.

Comments

Post a Comment

Popular posts from this blog

Kajol recalls struggling with body-shaming in Bollywood

Image
Kajol's journey began with early criticism for her appearance, but she rose to fame with 'Baazigar.' She found love with Ajay Devgn after initial friendships, leading to a marriage that has lasted over two decades. Kajol emphasizes the importance of continuous effort and adaptation in a marriage, alongside embracing one's true self despite societal pressures.
Read more